BioDot Inc. of Irvine had plans to scale in 2020. It didn’t anticipate a global pandemic, which drove demand higher than ever before for its ultra low-volume dispensers that are used to dispense ...

IRVINE, Calif.--(BUSINESS WIRE)--To support increasing demand globally for COVID-19 testing, BioDot has compressed production times for most new lateral flow dispensing platforms from months to four ...

The need for accessible, convenient and rapid testing over the course of the pandemic pushed the FDA to temporarily approve over-the-counter COVID-19 tests. That’s one result of the past year that ...

A recurring feature of the COVID-19 pandemic has been the improved disease control in countries that employed wide-scale testing from the beginning of the outbreak and the struggle of many governments ...